Bad news and good news in AD, and how to reconcile them

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

2018 saw the failure of several large clinical trials that were based on the premise that reduction of amyloid-β levels is an effective treatment for symptomatic Alzheimer disease. Yet, over the same time period, good news also emerged about the diagnostic value of tau PET imaging.

Original languageEnglish (US)
JournalNature Reviews Neurology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Amyloid
Alzheimer Disease
Clinical Trials

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Bad news and good news in AD, and how to reconcile them. / Knopman, David S.

In: Nature Reviews Neurology, 01.01.2019.

Research output: Contribution to journalArticle

@article{d67842dc6902451096a57ef5b3e97b46,
title = "Bad news and good news in AD, and how to reconcile them",
abstract = "2018 saw the failure of several large clinical trials that were based on the premise that reduction of amyloid-β levels is an effective treatment for symptomatic Alzheimer disease. Yet, over the same time period, good news also emerged about the diagnostic value of tau PET imaging.",
author = "Knopman, {David S}",
year = "2019",
month = "1",
day = "1",
doi = "10.1038/s41582-018-0131-7",
language = "English (US)",
journal = "Nature Reviews Neurology",
issn = "1759-4758",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Bad news and good news in AD, and how to reconcile them

AU - Knopman, David S

PY - 2019/1/1

Y1 - 2019/1/1

N2 - 2018 saw the failure of several large clinical trials that were based on the premise that reduction of amyloid-β levels is an effective treatment for symptomatic Alzheimer disease. Yet, over the same time period, good news also emerged about the diagnostic value of tau PET imaging.

AB - 2018 saw the failure of several large clinical trials that were based on the premise that reduction of amyloid-β levels is an effective treatment for symptomatic Alzheimer disease. Yet, over the same time period, good news also emerged about the diagnostic value of tau PET imaging.

UR - http://www.scopus.com/inward/record.url?scp=85059779362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059779362&partnerID=8YFLogxK

U2 - 10.1038/s41582-018-0131-7

DO - 10.1038/s41582-018-0131-7

M3 - Article

JO - Nature Reviews Neurology

JF - Nature Reviews Neurology

SN - 1759-4758

ER -